Dr. Lal PathLabs has informed that the Board of Directors in their meeting held today August 13, 2024, approved the following(s): 1. Grant of Stock Options to eligible employees under Dr. Lal PathLabs Employee Stock Option Plan, 2022. The disclosure with respect to the above grant of Stock Options, as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure – A. 2. Allotment of 93,900 Equity Shares under Dr. Lal PathLabs Employee Stock Option Plan, 2022. Pursuant to the above allotment, the Paid-up Equity Share Capital of the Company increased to INR 83,57,42,520/- divided into 8,35,74,252 Equity Shares of INR 10/- each. 3. Ved Prakash Goel, Group Chief Financial Officer (KMP) of the Company has been re-designated as ‘Group Chief Financial Officer and Chief Executive Officer – International Business (KMP)’ with effect from August 13, 2024. The disclosure with respect to the above change in designation, as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure - B. The Board Meeting commenced at 8:05 am (IST) and concluded at 8:12 am (IST).
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7248.75 |
Max Healthcare Inst | 1166.60 |
Narayana Hrudayalay | 1286.30 |
Aster DM Healthcare | 486.85 |
Global Health | 1098.95 |
View more.. |